Bora Pharmaceuticals Co., LTD. (TPE:6472)

TPE:6472 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	85,394	77,712	64,612	31,121	12,446	10,634
Market Cap Growth	15.32%	20.27%	107.61%	150.04%	17.05%	89.60%
Enterprise Value	100,855	92,091	67,752	36,584	13,828	11,299
Last Close Price	688.00	615.77	515.22	254.86	101.35	86.26
PE Ratio	18.19	19.73	21.32	22.36	16.60	18.38
Forward PE	17.94	16.07	21.03	11.57	14.97	21.75
PS Ratio	4.01	4.04	4.55	2.97	2.54	5.91
PB Ratio	6.07	5.18	5.49	6.05	3.95	4.31
P/TBV Ratio	14.75	14.33	18.95	13.07	4.18	4.32
P/FCF Ratio	22.25	171.66	14.97	17.14	11.60	372.33
P/OCF Ratio	18.80	79.23	14.01	15.48	10.07	59.81
EV/Sales Ratio	4.73	4.79	4.77	3.49	2.82	6.28
EV/EBITDA Ratio	24.50	21.72	11.82	16.87	11.42	31.90
EV/EBIT Ratio	33.21	27.23	12.91	19.03	13.22	49.98
EV/FCF Ratio	26.28	203.42	15.70	20.15	12.89	395.62
Debt / Equity Ratio	1.26	1.26	0.42	1.48	0.70	1.17
Debt / EBITDA Ratio	4.09	4.36	0.86	3.44	1.80	7.88
Debt / FCF Ratio	4.63	41.91	1.16	4.18	2.07	100.89
Asset Turnover	0.50	0.54	0.59	0.70	0.68	0.35
Inventory Turnover	3.21	3.01	3.48	5.19	3.16	1.56
Quick Ratio	1.05	1.26	0.91	0.95	0.96	0.61
Current Ratio	1.45	1.71	1.29	1.17	1.52	1.15
Return on Equity (ROE)	39.21%	30.18%	36.34%	33.80%	26.69%	28.09%
Return on Assets (ROA)	4.77%	5.98%	13.70%	7.97%	9.10%	2.72%
Return on Capital (ROIC)	6.48%	8.33%	22.25%	13.27%	12.20%	3.36%
Return on Capital Employed (ROCE)	11.00%	10.60%	31.10%	15.70%	18.90%	4.80%
Earnings Yield	4.86%	5.07%	4.69%	4.47%	6.02%	5.44%
FCF Yield	4.49%	0.58%	6.68%	5.83%	8.62%	0.27%
Dividend Yield	1.70%	1.90%	1.94%	2.01%	2.01%	1.08%
Payout Ratio	29.68%	31.30%	20.43%	17.16%	14.64%	14.39%
Buyback Yield / Dilution	-10.55%	-8.17%	-4.93%	-1.41%	-0.86%	-7.55%
Total Shareholder Return	-8.85%	-6.28%	-2.99%	0.61%	1.16%	-6.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.